Table 5.
Fully adjusted linear regression model for the relation between HbA1C % (ADA standards) and comorbidities
| β-coefficient | 95% Confidence interval | p | |||
|---|---|---|---|---|---|
| Comorbidities: | |||||
| Cerebrovascular attack | 0.066 | -0.148 | To | 0.683 | 0.206 |
| Hypertension | 0.04 | -0.292 | To | 0.644 | 0.459 |
| Congestive cardiac failure | -0.003 | -0.608 | To | 0.57 | 0.949 |
| Benign prostatic hyperplasia | -0.103* | -1.787 | To | -0.005 | 0.049 |
| Chronic kidney disease | 0.088 | -0.022 | To | 1.495 | 0.057 |
| Dementia | -0.149** | -2.206 | To | -0.399 | 0.005 |
| Ischemic heart disease | -0.056 | -1 | To | 0.251 | 0.239 |
| Depression | -0.211*** | -2.551 | To | -0.874 | 0 |
| Diabetic leg amputation | 0.091 | -0.254 | To | 2.682 | 0.105 |
| Osteoporosis | 0.12* | 0.212 | To | 2.726 | 0.022 |
| Chronic obstructive pulmonary disease | 0.078 | -0.205 | To | 2.517 | 0.096 |
| Not related complications | 0.098 | 0.086 | To | 1.018 | 0.464 |
*Correlation is significant at the 0.05 level (2-tailed). **Correlation is significant at the 0.01 level (2-tailed). ***Correlation is significant at the 0.001 level (2-tailed)